Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment
European Journal of Dermatology · 2024
DOI: 10.1684/ejd.2024.4729 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Kazuyasu Fujii und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Mycosis Fungoides, Sezary Syndrome, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
- Department of Pathology, Kurume University School of Medicine, Fukuoka, Japan.
Zitieren
APA
Fujii, K., Yoshizaki, A., Matsuoka, A., Baba, N., Ohshima, K., & Kanekura, T. (2024). Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4729
Vancouver
Fujii K, Yoshizaki A, Matsuoka A, Baba N, Ohshima K, Kanekura T. Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4729
BibTeX
@article{Fujii2024,
author = {Fujii, Kazuyasu and Yoshizaki, Ai and Matsuoka, Atsuko and Baba, Naoko and Ohshima, Koichi and Kanekura, Takuro},
title = {Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment},
journal = {European Journal of Dermatology},
year = {2024},
doi = {10.1684/ejd.2024.4729}
}
EUVIMED